<DOC>
	<DOCNO>NCT02691897</DOCNO>
	<brief_summary>The aim study assess efficacy safety melatonin control blood sugar patient type 2 diabetes mellitus ( DM ) .</brief_summary>
	<brief_title>Melatonin 's Effects Treatment Of Diabetes Mellitus</brief_title>
	<detailed_description>Diabetes mellitus ( DM ) major public health problem increase worldwide incidence . The main cause increase incidence DM inactivity , obesity change dietary habit . Investigators think change awake-sleep cycle may also contribute high incidence DM recent year . Melatonin important component circadian system . Numerous experimental study demonstrate melatonin many beneficial actions.Melatonin potent antioxidant , reduce inflammatory process , lower blood pressure , improve lipid profile . Collectively , data suggest melatonin may useful control blood sugar patient DM . The aim study assess efficacy melatonin control blood sugar patient type 2 DM .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>Type 2 diabetes mellitus diagnosed endocrinologist six month FBS=120160mg/dl HbA1C &lt; 8 % Melatonin sensitivity Impaired fasting glucose ( IFG ) Impaired glucose tolerance ( IGT ) Under Insulin therapy Pregnancy Lactation Diabetic autonomic neuropathy orthostatic hypotension Renal failure ( Creatinin &gt; 1.5mg/dl ) Diabetic retinopathy Diabetic nephropathy Malignancy Alcohol use Liver disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Diabetes mellitus</keyword>
	<keyword>Melatonin</keyword>
	<keyword>Blood Glucose</keyword>
	<keyword>Therapeutics</keyword>
	<keyword>Pineal gland</keyword>
</DOC>